131 related articles for article (PubMed ID: 37278090)
21. In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus.
Tuntland T; Odinecs A; Pereira CM; Nosbisch C; Unadkat JD
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):198-206. PubMed ID: 9914604
[TBL] [Abstract][Full Text] [Related]
22. Immunolocalization of ABC drug transporters in human placenta from normal and gestational diabetic pregnancies.
Kozłowska-Rup D; Czekaj P; Plewka D; Sikora J
Ginekol Pol; 2014 Jun; 85(6):410-9. PubMed ID: 25029804
[TBL] [Abstract][Full Text] [Related]
23. Development and Verification of a Linked
Patilea-Vrana GI; Unadkat JD
Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
[TBL] [Abstract][Full Text] [Related]
24. Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model.
Conings S; Tseke F; Van den Broeck A; Qi B; Paulus J; Amant F; Annaert P; Van Calsteren K
Toxicol Appl Pharmacol; 2019 May; 370():14-23. PubMed ID: 30849458
[TBL] [Abstract][Full Text] [Related]
25. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
Pollex E; Lubetsky A; Koren G
Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430
[TBL] [Abstract][Full Text] [Related]
26. Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.
Pinto L; Bapat P; de Lima Moreira F; Lubetsky A; de Carvalho Cavalli R; Berger H; Lanchote VL; Koren G
Pharm Res; 2021 Apr; 38(4):647-655. PubMed ID: 33825113
[TBL] [Abstract][Full Text] [Related]
27. Transfer of methohexital across the perfused human placenta.
Herman NL; Li AT; Van Decar TK; Johnson RF; Bjoraker RW; Downing JW; Jones D
J Clin Anesth; 2000 Feb; 12(1):25-30. PubMed ID: 10773504
[TBL] [Abstract][Full Text] [Related]
28. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages.
Mathias AA; Hitti J; Unadkat JD
Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R963-9. PubMed ID: 15961534
[TBL] [Abstract][Full Text] [Related]
29. Transplacental pharmacokinetics of diclofenac in perfused human placenta.
Shintaku K; Hori S; Tsujimoto M; Nagata H; Satoh S; Tsukimori K; Nakano H; Fujii T; Taketani Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2009 May; 37(5):962-8. PubMed ID: 19204082
[TBL] [Abstract][Full Text] [Related]
30. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility.
Cygalova LH; Hofman J; Ceckova M; Staud F
J Pharmacol Exp Ther; 2009 Dec; 331(3):1118-25. PubMed ID: 19779128
[TBL] [Abstract][Full Text] [Related]
31. Bupivacaine transfer across the human term placenta. A study using the dual perfused human placental model.
Johnson RF; Herman N; Arney TL; Gonzalez H; Johnson HV; Downing JW
Anesthesiology; 1995 Feb; 82(2):459-68. PubMed ID: 7856904
[TBL] [Abstract][Full Text] [Related]
32. Expression of ABC Efflux transporters in placenta from women with insulin-managed diabetes.
Anger GJ; Cressman AM; Piquette-Miller M
PLoS One; 2012; 7(4):e35027. PubMed ID: 22558111
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Placental Efflux Transporters during Pregnancy Complications.
Kozlosky D; Barrett E; Aleksunes LM
Drug Metab Dispos; 2022 Oct; 50(10):1364-1375. PubMed ID: 34992073
[TBL] [Abstract][Full Text] [Related]
34. Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.
Szilagyi JT; Gorczyca L; Brinker A; Buckley B; Laskin JD; Aleksunes LM
Toxicol Sci; 2019 Apr; 168(2):394-404. PubMed ID: 30576553
[TBL] [Abstract][Full Text] [Related]
35. Efflux transporters of the human placenta.
Young AM; Allen CE; Audus KL
Adv Drug Deliv Rev; 2003 Jan; 55(1):125-32. PubMed ID: 12535577
[TBL] [Abstract][Full Text] [Related]
36. Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta.
Annola K; Karttunen V; Keski-Rahkonen P; Myllynen P; Segerbäck D; Heinonen S; Vähäkangas K
Toxicol Lett; 2008 Nov; 182(1-3):50-6. PubMed ID: 18790027
[TBL] [Abstract][Full Text] [Related]
37. Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo.
Zhang Y; Shipkova PA; Warrack BM; Nelson DM; Wang L; Huo R; Chen J; Panfen E; Chen XQ; Fancher RM; Ruan Q; Christopher LJ; Xue Y; Sinz M; Shen H
Drug Metab Dispos; 2023 Jul; 51(7):851-861. PubMed ID: 37055191
[TBL] [Abstract][Full Text] [Related]
38. (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.
Liow JS; Zoghbi SS; Hu S; Hall MD; Hines CS; Shetty HU; Araneta MD; Page EM; Pike VW; Kreisl WC; Herscovitch P; Gottesman MM; Theodore WH; Innis RB
Neuroimage; 2016 Sep; 138():134-140. PubMed ID: 27211474
[TBL] [Abstract][Full Text] [Related]
39. Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice.
Nishimura T; Ishii M; Tanaka H; Noguchi S; Ikeda T; Tomi M
J Pharm Sci; 2024 Feb; 113(2):486-492. PubMed ID: 37981232
[TBL] [Abstract][Full Text] [Related]
40. Differential bidirectional transfer of indinavir in the isolated perfused human placenta.
Sudhakaran S; Ghabrial H; Nation RL; Kong DC; Gude NM; Angus PW; Rayner CR
Antimicrob Agents Chemother; 2005 Mar; 49(3):1023-8. PubMed ID: 15728898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
